Datum Dental

Company Overview

Snapshot

Founded in January 2012 by Arie Goldhust, Datum Dental operates with 11–50 employees. The company was acquired by Dentsply Sirona in January 2021, marking a significant exit in the dental biomaterials sector.

Business overview

Datum Dental specializes in developing sugar cross-linked collagen products for regenerative dentistry, focusing on bone and soft tissue regeneration. The company's core technology, GLYMATRIX collagen cross-linking, enables the creation of biomaterial implants with enhanced stability and long-lasting effects, mimicking natural collagen. Datum Dental's product portfolio includes OSSIX Plus, a resorbable collagen membrane. These products serve the dental industry, providing advanced solutions for clinicians and patients in the medical devices, biomaterials, and tissue engineering sectors globally.

Strategic signal

In January 2021, Datum Dental was acquired by Dentsply Sirona. This acquisition by a major multinational dental product manufacturer validates Datum Dental's innovative GLYMATRIX collagen cross-linking technology and its OSSIX product line, signaling strong market demand for advanced regenerative dental solutions and a successful exit for the company.

Company Intelligence Q&A

What is Datum Dental's primary focus?

Datum Dental focuses on developing dental biomaterial products for tissue and bone regeneration, utilizing sugar cross-linked collagen technology.

When was Datum Dental founded?

Datum Dental was founded in January 2012.

What is Datum Dental's proprietary technology?

Datum Dental's proprietary technology is GLYMATRIX collagen cross-linking, which is used to engineer biomaterial implants with enhanced stability and properties similar to natural collagen.

Which company acquired Datum Dental?

Datum Dental was acquired by Dentsply Sirona in January 2021.

What regulatory approvals did Datum Dental's OSSIX Bone receive?

In June 2018, Datum Dental's OSSIX Bone received CE Mark and Health Canada Regulatory Approvals.